Co-Authors
This is a "connection" page, showing publications co-authored by HOP S. TRAN CAO and CHING-WEI DAVID TZENG.
Connection Strength
6.368
-
CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2024 Nov 08.
Score: 0.247
-
Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol. 2025 Jan; 32(1):438-439.
Score: 0.246
-
A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford). 2024 Nov; 26(11):1379-1386.
Score: 0.243
-
Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. 2024 Jun 03; 29(6):e803-e810.
Score: 0.240
-
Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases. J Gastrointest Surg. 2024 Jul; 28(7):1181-1184.
Score: 0.239
-
Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. 2024 Jul; 233:17-23.
Score: 0.232
-
A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. 2024 Mar; 31(3):1833.
Score: 0.231
-
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
Score: 0.228
-
Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 07; 25(7):758-765.
Score: 0.220
-
Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes? HPB (Oxford). 2023 04; 25(4):472-480.
Score: 0.219
-
Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. 2023 01; 225(1):53-57.
Score: 0.214
-
Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. 2022 Dec; 29(13):8455.
Score: 0.213
-
Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res. 2022 10; 278:111-118.
Score: 0.208
-
Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. 2022 Sep; 126(4):658-666.
Score: 0.208
-
Prospective Implementation of Standardized Post-Hepatectomy Care Pathways to Reduce Opioid Prescription Volume after Inpatient Surgery. J Am Coll Surg. 2022 07 01; 235(1):41-48.
Score: 0.207
-
Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection. Ann Surg Oncol. 2022 Aug; 29(8):5156-5164.
Score: 0.207
-
Robotic Completion Radical Cholecystectomy with Fluorescence Guidance. Ann Surg Oncol. 2021 Oct; 28(11):6834.
Score: 0.193
-
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Ann Surg Oncol. 2021 Oct; 28(11):6725-6735.
Score: 0.191
-
Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization. J Hepatocell Carcinoma. 2020; 7:155-158.
Score: 0.186
-
Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020 08; 272(2):e106-e111.
Score: 0.184
-
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. 2020 Sep; 34:182-185.
Score: 0.181
-
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.
Score: 0.116
-
Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol. 2024 Dec 04.
Score: 0.062
-
Utilizing Patient-derived Xenografts to Model Precision Oncology for Biliary Tract Cancer. Clin Cancer Res. 2024 Nov 08.
Score: 0.062
-
Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med. 2024 Jun; 13(12):e7434.
Score: 0.060
-
Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford). 2024 07; 26(7):911-918.
Score: 0.059
-
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
Score: 0.059
-
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
Score: 0.058
-
Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg. 2023 Dec 26; 409(1):16.
Score: 0.058
-
Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5405.
Score: 0.057
-
Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 11; 27(11):2388-2395.
Score: 0.057
-
ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 09; 30(9):5401-5402.
Score: 0.056
-
Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5390-5400.
Score: 0.056
-
Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911.
Score: 0.056
-
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist. 2023 04 06; 28(4):327-332.
Score: 0.055
-
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer. 2023 Aug; 12(3):198-208.
Score: 0.055
-
Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
Score: 0.054
-
Technique for Robotic Pancreaticojejunostomy. J Am Coll Surg. 2023 05 01; 236(5):e12-e14.
Score: 0.054
-
Bintrafusp alfa, an anti-PD-L1:TGF-? trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun. 2022 09; 2(9):979-986.
Score: 0.053
-
Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.
Score: 0.053
-
Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023 Apr; 30(4):523-531.
Score: 0.053
-
Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci. 2022 Jul; 9:109-116.
Score: 0.052
-
Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. 2022 07 01; 128(13):2529-2539.
Score: 0.052
-
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med. 2021 Dec 01; 11(12).
Score: 0.050
-
Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases. J Gastrointest Surg. 2022 04; 26(4):791-801.
Score: 0.050
-
Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Ann Surg Oncol. 2022 Jan; 29(1):285.
Score: 0.050
-
Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. 2021 08 19; 108(8):968-975.
Score: 0.049
-
Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol. 2021 Dec; 39:101648.
Score: 0.049
-
Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal?Cancer. J Am Coll Surg. 2021 08; 233(2):272-284.e13.
Score: 0.049
-
Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases. J Am Coll Surg. 2021 07; 233(1):82-89.e1.
Score: 0.048
-
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
Score: 0.047
-
Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases. J Gastrointest Surg. 2021 01; 25(1):186-194.
Score: 0.047
-
External Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg. 2020 11; 231(5):e8-e10.
Score: 0.046
-
COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med. 2020 Apr 30; 2(2):135-137.
Score: 0.045